Real-World Evidence of Novel Anticoagulants: Safety and Efficacy Profiles in Diverse Populations
Received Date: Jul 27, 2024 / Published Date: Aug 26, 2024
Abstract
Anticoagulants play a crucial role in the management of thromboembolic disorders, with novel anticoagulants (NOACs) providing significant advancements over traditional therapies. This article reviews real-world evidence on the safety and efficacy profiles of NOACs across diverse populations, including different age groups, ethnicities, and co-morbid conditions. By analyzing data from large-scale observational studies and registries, we evaluate the effectiveness of NOACs in preventing stroke and systemic embolism in atrial fibrillation, venous thromboembolism, and other indications. Additionally, we explore the variations in safety outcomes, such as bleeding risks and adverse events, highlighting how real-world experiences align or differ from clinical trial findings. This review aims to provide a comprehensive understanding of NOACs' performance in varied clinical settings, informing treatment decisions and future research directions.
Citation: Baraka S (2024) Real-World Evidence of Novel Anticoagulants: Safetyand Efficacy Profiles in Diverse Populations Clin Pharmacol Biopharm, 13: 485.
Copyright: © 2024 Baraka S. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open 91桃色 Journals
Article Usage
- Total views: 705
- [From(publication date): 0-2024 - Aug 24, 2025]
- Breakdown by view type
- HTML page views: 469
- PDF downloads: 236
